<?xml version="1.0" encoding="UTF-8"?>
<sec id="Sec20" sec-type="results" class="sec">
 <div class="title" xmlns="http://www.w3.org/1999/xhtml">Results</div>
 <sec id="Sec21" class="sec">
  <div class="title" xmlns="http://www.w3.org/1999/xhtml">Chemical analysis</div>
  <p xmlns="http://www.w3.org/1999/xhtml">Chemical analyses (GC and GC/MS) of AcEO allowed the identification of 42 compounds. The chromatographic profile of the essential oil is shown in (Fig. 
   <a rid="Fig1" ref-type="fig" href="#Fig1">1</a>). The oil has the spathulenol (10.19%) as main component, followed by ß-eudesmol (4.05%), p-cymene (3.83%), δ-cadinene (3.67%), ß-pinene (2.82%), caryophyllene oxide (2.30%) and salvial-4(14)-en-1-one (2.51%). The compounds mentioned in Fig. 
   <a rid="Fig1" ref-type="fig" href="#Fig1">1</a> were systematically found in all the samples. The chemical structures of the major chemical components found in AcEO are presented in (Fig. 
   <a rid="Fig2" ref-type="fig" href="#Fig2">2</a>).
   <div id="Fig1" class="fig">
    <span class="label">Fig. 1</span>
    <div class="caption">
     <p>GC-MS chromtogram of 
      <span class="italic">A. campestris</span> L. essential oil (AcEO)
     </p>
    </div>
    <div xlink:href="12906_2017_1598_Fig1_HTML" id="MO1" class="graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/>
   </div>
   <div id="Fig2" class="fig">
    <span class="label">Fig. 2</span>
    <div class="caption">
     <p>Chemical structures of volatiles compounds of 
      <span class="italic">A. campestris</span> L. essential oil (AcEO)
     </p>
    </div>
    <div xlink:href="12906_2017_1598_Fig2_HTML" id="MO2" class="graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/>
   </div>
  </p>
 </sec>
 <sec id="Sec22" class="sec">
  <div class="title" xmlns="http://www.w3.org/1999/xhtml">β-Carotene bleaching assay</div>
  <p xmlns="http://www.w3.org/1999/xhtml">The prevention of β-carotene bleaching with linoleic acid was similarly effective for AcEO (AA
   <sub>max</sub>% = 82.2% ± 12.7) and the standard ascorbic acid (AA 
   <sub>max</sub> % = 86.65% ± 6.45) and the antioxidant effect of both tested substrates was higher than 50% (Fig. 
   <a rid="Fig3" ref-type="fig" href="#Fig3">3a</a>).
   <div id="Fig3" class="fig">
    <span class="label">Fig. 3</span>
    <div class="caption">
     <p>Antioxidant effect of 
      <span class="italic">A.campestris</span> L. essential oil (AcEO) and ascorbic acid on (
      <span class="bold">a</span>) the scavenging of 2, 2(diphenyl-1-picryhydrazyl (DPPH) radical (
      <span class="bold">b</span>) the prevention of β-carotene bleaching and; Values are mean ± SEM, 
      <span class="italic">n</span> = 3, and analyzed with linear regression test
     </p>
    </div>
    <div xlink:href="12906_2017_1598_Fig3_HTML" id="MO3" class="graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/>
   </div>
  </p>
 </sec>
 <sec id="Sec23" class="sec">
  <div class="title" xmlns="http://www.w3.org/1999/xhtml">DPPH radical scavenging assay</div>
  <p xmlns="http://www.w3.org/1999/xhtml">The radical scavenging activity of AcEO against DPPH radical increased significantly in dose-dependent manner (Fig. 
   <a rid="Fig3" ref-type="fig" href="#Fig3">3b</a>); the EC
   <sub>50</sub> values calculated from the graph was EC
   <sub>50</sub> = 690 μg/ml. However, the radical scavenging activity attributed to ascorbic acid seems to be more important, characterized by a linear and stable shape of the graph with a maximum of 96.23% of the antioxidant effect (AA % higher than 50%).
  </p>
 </sec>
 <sec id="Sec24" class="sec">
  <div class="title" xmlns="http://www.w3.org/1999/xhtml">Acute toxicity</div>
  <p xmlns="http://www.w3.org/1999/xhtml">During the experiment, animals treated with AcEO at 2 g/kg, showed several signs of intoxication like: hyperactivity succeeded by asthenia, tremors, convulsion and irregular breathing, yet, all these signs disappeared after the first 24 h. The same dose provoked minimal lethality (one animal dead), marked by an intense ulceration of gastric mucosa. However, no significant changes have been observed in organs and body weights monitored during 2 weeks succeeding AcEO injection.</p>
 </sec>
 <sec id="Sec25" class="sec">
  <div class="title" xmlns="http://www.w3.org/1999/xhtml">Antiplatelet effect</div>
  <p xmlns="http://www.w3.org/1999/xhtml">AcEO (0.1, 0.5 and 1 mg/ml) added to washed platelets inhibited aggregation triggered by thrombin (0.1 U/ml) and ADP (1 μM). The dose 1 mg/ml showed a maximum inhibitory effect of, respectively, 49.73% ± 9.54 (
   <span class="italic">p</span> &lt; 0.01) and 48.20% ± 8.49 (
   <span class="italic">p</span> &lt; 0.05) on thrombin and ADP -induced platelet aggregation. However the doses 0.1 mg/ml and 0.5 mg/ml of AcEO have no significant effect on the antiplatelet effect (Fig. 
   <a rid="Fig4" ref-type="fig" href="#Fig4">4</a>).
   <div id="Fig4" class="fig">
    <span class="label">Fig. 4</span>
    <div class="caption">
     <p>The originaltrcing and percentage of aggregation inhibition of 0.1, 0.5 and 1 mg/ml of 
      <span class="italic">A. campestris</span> L. essential oil (AcEO) on thrombin (
      <span class="bold">a</span>) and ADP (
      <span class="bold">b</span>) induced platelet aggregation. Values are mean ± SEM, 
      <span class="italic">n</span> = 6, analysed with one way ANOVA followed by Bonferroni’s post-test; 
      <span class="italic">p</span>* &lt; 0.005 vs control and ** &lt; 0.01 vs control
     </p>
    </div>
    <div xlink:href="12906_2017_1598_Fig4_HTML" id="MO4" class="graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/>
   </div>
  </p>
 </sec>
 <sec id="Sec26" class="sec">
  <div class="title" xmlns="http://www.w3.org/1999/xhtml">Determination of the mechanism underlying the vasorelaxant activity of AcEO</div>
  <sec id="Sec27" class="sec">
   <div class="title" xmlns="http://www.w3.org/1999/xhtml">Vasorelaxant effect of AcEO on denuded aorta, and on intact aorta preincubated with Atropine and Calmidazolium</div>
   <p xmlns="http://www.w3.org/1999/xhtml">AcEO (0.1–100 μg/ml) abolished the contraction induced by phenylephrine on intact thoracic aorta, and induced 95.97% ± 2.03 of vasorelaxation. The vasorelaxant effect induced by AcEO on denuded aorta (102.07% ± 3.01; 
    <span class="italic">p</span> &gt; 0.05), also, the pretreatment with calmidazolium (97.07% ± 3.29; 
    <span class="italic">p</span> &gt; 0.05), blocker of calcium-calmodulin binding to NO synthase, did not affect the vasorelaxation induced by AcEO. However, the vasorelaxation provoked by AcEO on aorta precontracted with phenylephrine has been partially inhibited, when preincubated with the muscarinic receptor inhibitor, atropine (85.69% ± 6.56; 
    <span class="italic">p</span> &lt; 0.05) (Fig. 
    <a rid="Fig5" ref-type="fig" href="#Fig5">5a</a>).
    <div id="Fig5" class="fig">
     <span class="label">Fig. 5</span>
     <div class="caption">
      <p>Concentration–response curves of the vasorelaxant effect of 
       <span class="italic">A. campestris</span> L. (AcEO) on (
       <span class="bold">a</span>) isolated aorta pre-contracted with phenylephrine 10
       <span class="sup">−6</span> M, on denuded aorta and on aorta pre-incubated with Atropine and Calmidazolium, (
       <span class="bold">b</span>) with L-NAME, Hydroxocobalamin, ODQ and 8-RP-Br-PET-cGMP. Values are mean ± SEM, 
       <span class="italic">n</span> = 6, and analyzed with two way ANOVA followed by Bonferroni’s post-test; * 
       <span class="italic">p</span> &lt; 0.05 vs control
      </p>
     </div>
     <div xlink:href="12906_2017_1598_Fig5_HTML" id="MO5" class="graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/>
    </div>
   </p>
  </sec>
  <sec id="Sec28" class="sec">
   <div class="title" xmlns="http://www.w3.org/1999/xhtml">Vasorelaxant effect of AcEO on aorta preincubated with L-NAME, Hydroxycobalamin, ODQ and 8-RP-Br-PET-cGMP</div>
   <p xmlns="http://www.w3.org/1999/xhtml">No significant difference on the vasorelaxation effect of AcEO (0.1–100 μg/ml) on phenylephrine precontracted aorta have been observed in the presence of NO synthase inhibitor; L-NAME (97.27% ± 2.82; 
    <span class="italic">p</span> &gt; 0.05), in the presence of NO scavenger; hydroxocobalamin (93.99% ± 2.32; 
    <span class="italic">p</span> &gt; 0.05), and in the presence of guanylyl cyclase inhibitor; ODQ (92.26% ± 3.91; 
    <span class="italic">p</span> &gt; 0.05). However, relative inhibitory effect AcEO-induced vasorelaxation have been observed in the presence of the competitive cGMP-dependent protein kinase G (PKG) inhibitor; Rp-8-Br-PET-cGMP (87.86% ± 4.28; 
    <span class="italic">p</span> &lt; 0.05) (Fig. 
    <a rid="Fig5" ref-type="fig" href="#Fig5">5b</a>).
   </p>
  </sec>
  <sec id="Sec29" class="sec">
   <div class="title" xmlns="http://www.w3.org/1999/xhtml">Vasorelaxant effect of AcEO on aorta preincubated with potassium channels blockers, TEA, 4-AP, BaCl2 and Glybenclamide</div>
   <p xmlns="http://www.w3.org/1999/xhtml">Pretreatment of aorta with potassium channels blockers; TEA (98.91% ± 3, 73; 
    <span class="italic">p</span> &gt; 0.05), 4-AP (98.05% ± 2.96; 
    <span class="italic">p</span> &gt; 0.05), BaCl
    <sub>2</sub> (103.52% ± 2.47; p &gt; 0.05) and glybenclamide (99.55% ± 2.66; 
    <span class="italic">p</span> &gt; 0.05), showed no significant changes in AcEO (0.1–100 μg/ml) induced-vasorelaxation (Fig. 
    <a rid="Fig6" ref-type="fig" href="#Fig6">6a</a>).
    <div id="Fig6" class="fig">
     <span class="label">Fig. 6</span>
     <div class="caption">
      <p>Concentration–response curves of the vasorelaxant effect of 
       <span class="italic">A. campestris</span> L. (AcEO) on (
       <span class="bold">a</span>) isolated aorta pre-contracted with Phen 1 μM, and in the presence of TEA, 4-AP, BaCl
       <sub>2</sub> and Glibenclamide, and in the presence of (
       <span class="bold">b</span>) Thapsigargin, Verapamil and Indomethacin. Values are mean ± SEM, 
       <span class="italic">n</span> = 6, and analyzed with two way ANOVA followed by Bonferroni’s post-test; *** 
       <span class="italic">p</span> &lt; 0.001 vs control
      </p>
     </div>
     <div xlink:href="12906_2017_1598_Fig6_HTML" id="MO6" class="graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/>
    </div>
   </p>
  </sec>
  <sec id="Sec30" class="sec">
   <div class="title" xmlns="http://www.w3.org/1999/xhtml">Vasorelaxant effect of AcEO on aorta preincubated with Indomethacin, Thapsigargin and Verapamil</div>
   <p xmlns="http://www.w3.org/1999/xhtml">Pretreatment of aorta with cyclooxygenase inhibitor; indomethacin (92.95% ± 2.73; 
    <span class="italic">p</span> &gt; 0.05) did not produce any significant difference of vasorelaxation induced by AcEO precontracted with phenylephrine. Therefore, aorta preincubated with endoplasmic reticulum calcium-ATPase inhibitor; thapsigargin (45.34% ± 6.58; 
    <span class="italic">p</span> &lt; 0.001), and calcium channel type VOC blocker; verapamil (48.12% ± 8.21; 
    <span class="italic">p</span> &lt; 0.001) produced a sub-maximum inhibitory effect of vasorelaxation induced by AcEO (0.1–100 μg/ml) (Figs. 
    <a rid="Fig6" ref-type="fig" href="#Fig6">6b</a> and 
    <a rid="Fig7" ref-type="fig" href="#Fig7">7</a>).
    <div id="Fig7" class="fig">
     <span class="label">Fig. 7</span>
     <div class="caption">
      <p>Original tracing showing the vasorelaxant effect of 
       <span class="italic">A. campestris</span> L. essential oil (AcEO) on isolated aorta pre-contracted with Phen 1 μM (
       <span class="bold">a</span>) and in the presence of Verapamil (
       <span class="bold">b</span>) and Thapsigargin (
       <span class="bold">c</span>)
      </p>
     </div>
     <div xlink:href="12906_2017_1598_Fig7_HTML" id="MO7" class="graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/>
    </div>
   </p>
  </sec>
  <sec id="Sec31" class="sec">
   <div class="title" xmlns="http://www.w3.org/1999/xhtml">Vasorelaxant effect of AcEO on aorta precontracted with Phen (1 μM) and K
    <span class="sup">+</span> (80 mM) and comparative vasorelaxant effect of cumulative doses of ACEO and Verapamil on K
    <span class="sup">+</span> (80 mM)
   </div>
   <p xmlns="http://www.w3.org/1999/xhtml">As shown in Fig. 
    <a rid="Fig8" ref-type="fig" href="#Fig8">8</a>, AcEO triggered a concentration-dependent vasodilation against Phen (1 μM) and K
    <span class="sup">+</span> (80 mM) induced vasocontractions, with respective EC
    <sub>50</sub> value of 0.005 mg/ml (
    <span class="italic">n</span> = 6) and 0.019 mg/ml (
    <span class="italic">n</span> = 6). In parallel, AcEO and verapamil administered in increasing doses to the plateau of K
    <span class="sup">+</span> (80 mM), showed a similar vasorelaxant profile with respective E
    <sub>max</sub> values of (97,04% + 4,08; 
    <span class="italic">n</span> = 6) and (94,97% + 3,35; 
    <span class="italic">n</span> = 6) (Fig. 
    <a rid="Fig9" ref-type="fig" href="#Fig9">9</a>).
    <div id="Fig8" class="fig">
     <span class="label">Fig. 8</span>
     <div class="caption">
      <p>The originaltrcing (
       <span class="bold">a</span>) and the concentration–response curves (
       <span class="bold">b</span>) of the vasorelaxant effect of 
       <span class="italic">A. campestris</span> L. essential oil (AcEO) on Phen (1 μM) and on K
       <span class="sup">+</span> (80 mM)-induced contraction. Values are mean ± SEM, 
       <span class="italic">n</span> = 6, and analyzed with non linear regression test
      </p>
     </div>
     <div xlink:href="12906_2017_1598_Fig8_HTML" id="MO8" class="graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/>
    </div>
    <div id="Fig9" class="fig">
     <span class="label">Fig. 9</span>
     <div class="caption">
      <p>The original tracing (
       <span class="bold">a</span>) and the concentration–response curves (
       <span class="bold">b</span>) of the vasorelaxant effect of 
       <span class="italic">A. campestris</span> L. essential oil (AcEO) and Verapamil on K
       <span class="sup">+</span> (80 mM)-induced contraction. Values are mean ± SEM, 
       <span class="italic">n</span> = 6, and analyzed with linear regression test
      </p>
     </div>
     <div xlink:href="12906_2017_1598_Fig9_HTML" id="MO9" class="graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/>
    </div>
   </p>
  </sec>
 </sec>
</sec>
